NEW YORK and HAIKOU CITY, China, July 2 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (''China Pharma'') (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio- pharmaceutical products in China, today announced that the management will present at the Collins Stewart Fourth Annual Growth Conference on Tuesday, July 8th at 2:00 p.m. EDT. The conference is being held at the Mandarin Oriental Hotel in New York City, NY.
Mr. Xinhua Wu, China Pharma's CFO, and two senior managers Mr. Sam Hsing and Ms. Mary Wyatt will be representing China Pharma at the conference and will be available for one-on-one meetings with analysts and investors throughout the day. Mr. Hsing and Ms. Wyatt joined the Company recently. Mr. Hsing holds a Master degree in finance from University of Plymouth. Ms. Wyatt graduated from Manchester University with a BS in Molecular Biology and has studied and worked in China since 1999. They are both English-speaking members of senior management and will assist the Company in public financial and investor communications.
Management will discuss the Company's current product portfolio, development pipeline, research and development platform, recent financial highlights and its long-term growth strategy.
Participation is by invitation and registration is mandatory. For more information on the conference contact your Collins Stewart representative or visit http://www.collins-stewart.com .
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic
and brand bio-pharmaceutical products in China that treat a wide range of
conditions, including infections, hepatitis, cardiovascular and CNS
diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co.,
Ltd (Helpson), a specialty pharmaceutical company headquartered in Haikou
City, Hainan province in China, i
|SOURCE China Pharma Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved